Dr. Jesse Wolfstadt to lead elite orthopaedic surgery team

Led by Dr. Jesse Wolfstadt, the new Orthopaedic Surgery Division Head at Mount Sinai, the team focuses on hip and knee reconstruction, including primary joint replacements and complex revisions. They also focus on sarcoma care, which involves treating bone and soft tissue cancers.

Dr. Wolfstadt’s vision is to continue building a collaborative team focused on providing compassionate patient-centred care. He is also determined to continue our legacy as a world leader in complex orthopaedic surgeries.

"Patients travel from around the world to see us, and top learners want to study here under world-renowned orthopaedic experts," says Dr. Wolfstadt. "Our goal is to ensure we remain at the forefront of innovation and excellence."

By bringing together experts across sub-specialties, Dr. Wolfstadt ensures his team can provide comprehensive care for the most challenging cases. It is rare to find such a wide range of expertise in one place.

Innovating with same-day recovery and robotics

Dr. Wolfstadt is excited about the evolution of the same-day recovery program for hip and knee replacements. This approach improves patient outcomes and allows us to effectively serve more patients.

“The team is also embracing robotic-assisted surgery to enhance precision in joint replacements,” says Dr. Wolfstadt. “Although evidence is still emerging about how robotics can help long-term, there is no doubt that patients are actively seeking out surgeons who perform robotic-assisted joint replacements.”

A personal connection to Mount Sinai

For Dr. Wolfstadt, Sinai Health is more than just a workplace — it’s home. His mother worked as an Emergency Department nurse in the 1980s. Later, she was an office nurse for Dr. Paul Bernstein who delivered Dr. Wolfstadt and his sister at the hospital.

“This place has always felt like family to me,” he reflects. “From medical school to residency and now leading the division, Mount Sinai has played an instrumental role in my career. It’s where I’ve always wanted to be.”

The future of orthopaedics

Looking ahead, Dr. Wolfstadt and his team aim to expand the sarcoma and arthroplasty (joint replacement) programs to address long waitlists. He also plans to increase research infrastructure and make Mount Sinai a leading center for randomized clinical trials in orthopaedic surgery.

“We want to continue refining our patient care pathways and growing our program so that we remain the last stop for complex cases,” he says. “Patients and physicians trust us to handle the toughest cases, and we take that responsibility seriously.”